Correlation Between Oneness Biotech and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oneness Biotech and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oneness Biotech and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oneness Biotech Co and Medigen Vaccine Biologics, you can compare the effects of market volatilities on Oneness Biotech and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oneness Biotech with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oneness Biotech and Medigen Vaccine.

Diversification Opportunities for Oneness Biotech and Medigen Vaccine

0.96
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Oneness and Medigen is 0.96. Overlapping area represents the amount of risk that can be diversified away by holding Oneness Biotech Co and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and Oneness Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oneness Biotech Co are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of Oneness Biotech i.e., Oneness Biotech and Medigen Vaccine go up and down completely randomly.

Pair Corralation between Oneness Biotech and Medigen Vaccine

Assuming the 90 days trading horizon Oneness Biotech Co is expected to under-perform the Medigen Vaccine. In addition to that, Oneness Biotech is 1.08 times more volatile than Medigen Vaccine Biologics. It trades about -0.05 of its total potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about -0.05 per unit of volatility. If you would invest  7,520  in Medigen Vaccine Biologics on August 31, 2024 and sell it today you would lose (3,630) from holding Medigen Vaccine Biologics or give up 48.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy99.78%
ValuesDaily Returns

Oneness Biotech Co  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
Oneness Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oneness Biotech Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Oneness Biotech and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oneness Biotech and Medigen Vaccine

The main advantage of trading using opposite Oneness Biotech and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oneness Biotech position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind Oneness Biotech Co and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets